Europe restricts use of metoclopramide

26 July 2013 - Deborah Wilkes

Archived

The European Medicines Agency (EMA) has recommended changes to the use of metoclopramide-containing medicines to "minimise the known risks of potentially-serious neurological side-effects".

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: